Is it worthwhile to try different coenzymatic forms of folate in future chemoprevention trials?
Choi
S W
SW
Friso
S
S
D000818:Animals; D002455:Cell Division / Q000187:drug effects; D002986:Clinical Trials as Topic; D003110:Colonic Neoplasms / Q000473:pathology / Q000517:prevention & control*; D019175:DNA Methylation / Q000187:drug effects; D005492:Folic Acid / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use*; D006706:Homeostasis; D006801:Humans; D042965:Methylenetetrahydrofolate Reductase (NADPH2); D000587:Oxidoreductases Acting on CH-NH Group Donors / Q000235:genetics / Q000378:metabolism; D014407:Tumor Cells, Cultured
D005492:Folic Acid; D000587:Oxidoreductases Acting on CH-NH Group Donors; D042965:Methylenetetrahydrofolate Reductase (NADPH2)